- General Anesthesia
- Regional Anesthesia
- Local Anesthesia
- Other
Anesthesia Drugs Market size was valued at USD 8,725.6 million in 2023 and is expected to grow at a CAGR of 3.8% from 2024 - 2030. The anesthesia drug market is expanding due to some significant factors an increase in the prevalence of chronic diseases such as cancer, cardiovascular disease, and osteoarthritis; a rise in demand for inhalation anesthesia; an increase in funding from private & government organizations for the development of pharmaceutical manufacturing segments; and rise in R&D activities for the formulation of a general anesthesia drug. The rise in funding from public and private organizations for the development of pharmaceutical manufacturing segments; and the rise in research and development efforts for the formulation of general anesthesia drugs are the main factors driving the growth of the global market share for general anesthesia drugs.
Furthermore, the World Health Organization revealed in 2022 that the leading cause of mortality worldwide is cardiovascular disease. Individuals who suffer from atrial fibrillation, heart failure, or coronary heart disease are more likely to require open heart surgery. Under general anesthesia, open heart surgery is performed. This element fuels the market's expansion. The United States had severe shortages of essential anesthetic medications following the emergence of COVID-19, including dexmedetomidine, midazolam, propofol, and neuromuscular blocking medicines. As a result, a lot of businesses are producing more anesthetic medications.
For example, Hikma Pharmaceutical debuted "Propofol Injectable Emulsion," a new medicine, in the US market in May 2020. Emerging markets expansion, innovation in drug development, integration of advanced technologies, personalized medicine, expansion of ambulatory and outpatient surgery centers, strategic partnerships and collaborations, opioid-sparing strategies, regenerative medicine, and new techniques. Additionally, advances in technology in the delivery of Drugs, the development of specifically targeted medicines, the development of devices to monitor patient's physiological parameters during and after Anesthesia, and reduced side effects of anesthetics are the opportunities that will boost the market growth.
Study Period
2024 - 2030Base Year
2023CAGR
3.8%Largest Market
North AmericaFastest Growing Market
Asia pacific
The anesthesia drug market's increasing number of surgeries, the aging population with an increase in chronic illnesses, and the developments in anesthetic technologies are further factors propelling this market. The American Society of Plastic Surgeons (ASPS) estimates that in 2020, 6.1 million cosmetic treatments were carried out on individuals between the ages of 40 and 54, and around 768,000 procedures were conducted on those between the ages of 10 and 29. These figures show that the number of surgeries performed in the area is steadily rising, which in turn is fueling the need for anesthetic medications. The market is anticipated to develop substantially as a result of the use of anesthetics in general operations. Thus, all aforementioned factors, such as the increasing number of surgical procedures and product launches, boost the market over the forecast period. The scarcity of healthcare facilities in developing nations and isolated locations, as well as the dearth of anesthesia physicians and certified anesthesia nurses per capita, is predicted to be a growth inhibitor for the anesthesia drugs market. High costs for procedures and branded drugs could hinder this market's expansion during the forecast period. Another factor hurting the market for anesthesia drugs is the general public's ignorance of anesthesia.
By Type
By Drugs
By Route of Administration
By End Users
The anaesthesia drug market was valued at USD 8,725.6 million in 2023 and is expected to grow at a CAGR of 3.8% over the forecast period.
An increasing number of surgical procedures, a rising geriatric population, advances in anesthesia technology, a growing prevalence of chronic diseases, and an expanding healthcare infrastructure are the key drivers in the anesthesia drug market.
The prevalence of chronic illnesses like cancer, heart disease, and osteoarthritis is rising. In addition, there is a growing need for inhalation anesthesia. These are the main trends in the market for general anesthesia drugs.
Biomedical Research Models (Biomere), Transpogen Biopharmaceutical, Inc., Pfizer Inc., Heritage Pharmaceuticals Inc., Piramal Enterprises Limited, Sanofi Fresenius SE & Co, Novartis AG, AbbVie the key players in the anesthesia drugs market.
Asai-Pacific is the fastest-growing region in the anesthesia drug market.
1. Executive Summary |
2. Global Anesthesia Drugs Market Introduction |
2.1.Global Anesthesia Drugs Market - Taxonomy |
2.2.Global Anesthesia Drugs Market - Definitions |
2.2.1.Type |
2.2.2.Drugs |
2.2.3.Route of Administration |
2.2.4.End Users |
2.2.5.Region |
3. Global Anesthesia Drugs Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Anesthesia Drugs Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Anesthesia Drugs Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. General Anesthesia |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Regional Anesthesia |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Local Anesthesia |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Other |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Global Anesthesia Drugs Market By Drugs, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. General Anesthetics |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Local Anesthetics |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Anesthesia Drugs Market By Route of Administration , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Engine |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Flight Control System |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Aerostructure |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Landing Gear |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8. Global Anesthesia Drugs Market By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Ambulatory surgical center |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9. Global Anesthesia Drugs Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America Anesthesia Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.General Anesthesia |
10.1.2.Regional Anesthesia |
10.1.3.Local Anesthesia |
10.1.4.Other |
10.2. Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.General Anesthetics |
10.2.2.Local Anesthetics |
10.2.3.Others |
10.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Engine |
10.3.2.Flight Control System |
10.3.3.Aerostructure |
10.3.4.Landing Gear |
10.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Ambulatory surgical center |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe Anesthesia Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.General Anesthesia |
11.1.2.Regional Anesthesia |
11.1.3.Local Anesthesia |
11.1.4.Other |
11.2. Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.General Anesthetics |
11.2.2.Local Anesthetics |
11.2.3.Others |
11.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Engine |
11.3.2.Flight Control System |
11.3.3.Aerostructure |
11.3.4.Landing Gear |
11.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Ambulatory surgical center |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) Anesthesia Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.General Anesthesia |
12.1.2.Regional Anesthesia |
12.1.3.Local Anesthesia |
12.1.4.Other |
12.2. Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.General Anesthetics |
12.2.2.Local Anesthetics |
12.2.3.Others |
12.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Engine |
12.3.2.Flight Control System |
12.3.3.Aerostructure |
12.3.4.Landing Gear |
12.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Ambulatory surgical center |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13. Middle East and Africa (MEA) Anesthesia Drugs Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.General Anesthesia |
13.1.2.Regional Anesthesia |
13.1.3.Local Anesthesia |
13.1.4.Other |
13.2. Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.General Anesthetics |
13.2.2.Local Anesthetics |
13.2.3.Others |
13.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Engine |
13.3.2.Flight Control System |
13.3.3.Aerostructure |
13.3.4.Landing Gear |
13.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Ambulatory surgical center |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America Anesthesia Drugs Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.General Anesthesia |
14.1.2.Regional Anesthesia |
14.1.3.Local Anesthesia |
14.1.4.Other |
14.2. Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.General Anesthetics |
14.2.2.Local Anesthetics |
14.2.3.Others |
14.3. Route of Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Engine |
14.3.2.Flight Control System |
14.3.3.Aerostructure |
14.3.4.Landing Gear |
14.4. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Ambulatory surgical center |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Charles River Laboratories International, Inc. |
15.2.2.The Jackson Laboratory |
15.2.3.Laboratory Corporation of America Holdings (Covance) |
15.2.4.Perkin Elmer (Horizon Discovery Group plc) |
15.2.5.Biomedical Research Models (Biomere) |
15.2.6.Transpogen Biopharmaceutical, Inc. |
15.2.7.Pfizer Inc |
15.2.8.Heritage Pharmaceuticals Inc. |
15.2.9.Piramal Enterprises Limited |
15.2.10.Sanofi Fresenius SE & Co |
15.2.11.Novartis AG |
15.2.12.AbbVie |
16. Research Methodology |
17. Appendix and Abbreviations |